Form 8-K - Current report:
SEC Accession No. 0001144204-15-057409
Filing Date
2015-09-30
Accepted
2015-09-30 16:15:28
Documents
3
Period of Report
2015-09-25
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v421319_8-k.htm 8-K 20794
2 EXHIBIT 99.1 v421319_ex99-1.htm EX-99.1 13253
3 GRAPHIC logo.jpg GRAPHIC 4339
  Complete submission text file 0001144204-15-057409.txt   41285
Mailing Address 20 FIRSTFIELD ROAD GAITHERSBURG MD 20878
Business Address 20 FIRSTFIELD ROAD GAITHERSBURG MD 20878 240-268-2000
NOVAVAX INC (Filer) CIK: 0001000694 (see all company filings)

EIN.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26770 | Film No.: 151133918
SIC: 2836 Biological Products, (No Diagnostic Substances)